3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Submental Fat: new trials by email Literature Review of Submental Fat trials Research Report on Submental Fat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat MT921, Placebo - Submental Fat | Phase 3 | Completed | Medy-Tox | 240 | 2021-12-24 | 2023-02-23 |
| Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat Normal saline, DWJ211 - Submental Fat | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 148 | 2019-05-15 | 2024-04-04 |
| Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 ATX-101, Placebo - Submental Fat, Healthy | Phase 3 | Completed | Kythera Biopharmaceuticals | 224 | 2013-12-01 | 2020-02-17 |
Saline Solution (1)
Daewoong Pharmaceutical Co. LTD. (1) · Kythera Biopharmaceuticals (1) · Medy-Tox (1)
South Korea (2) · Canada (1) · United States (1)
Frederick Beddingfield, III, MD, PhD (1)